Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

April 15, 2026 12:30 ET | Source: Basilea Pharmaceutica International Ltd, Allschwil

Basilea-Aktionäre genehmigen an der Generalversammlung 2026 alle Anträge des Verwaltungsrats

Allschwil, 15. April 2026 Basilea Pharmaceutica AG, Allschwil (SIX: BSLN), ein biopharmazeutisches Unternehmen mit bereits vermarkteten Produkten und dem Ziel, Patienten zu helfen, die an schweren...
April 15, 2026 12:30 ET | Source: Basilea Pharmaceutica International Ltd, Allschwil

Basilea shareholders approve all proposals of the board of directors at the 2026 annual general meeting

Allschwil, Switzerland, April 15, 2026 Basilea Pharmaceutica Ltd, Allschwil (SIX: BSLN), a commercial-stage biopharmaceutical company committed to meeting the needs of patients with severe bacterial...
April 14, 2026 08:30 ET | Source: Draganfly Inc

Draganfly CEO Cameron Chell Addresses Canadian Senate on Strengthening National Defence Capability

Ottawa, ON, April 14, 2026 (GLOBE NEWSWIRE) -- Draganfly Inc. (NASDAQ: DPRO; CSE: DPRO) (“Draganfly” or the “Company”), an award-winning, industry-leading drone solutions and systems developer,...
April 10, 2026 08:30 ET | Source: Draganfly Inc

Draganfly CEO Cameron Chell to Appear on Fox Business’ Making Money with Charles Payne to Discuss Iran Conflict and the Strategic Role of Drone Warfare

New York, NY, April 10, 2026 (GLOBE NEWSWIRE) -- Draganfly Inc. (NASDAQ: DPRO; CSE: DPRO; FSE: 3U8A) (“Draganfly” or the “Company”), an award-winning, industry-leading developer of drone solutions...
April 09, 2026 10:30 ET | Source: Multitude AG

Multitude AG: Mr Jorma Jokela, Receipt of a share-based incentive; Transaction linked to the exercise of share option programmes

Multitude AG: Mr Jorma Jokela, Receipt of a share-based incentive; Transaction linked to the exercise of share option programmes Notification and public disclosure of transactions by persons...
April 09, 2026 09:00 ET | Source: Globex Mining Enterprises Inc.

Antimony Resources Reports Progress on the Bald Hill Property Under Option from Globex

TORONTO, April 09, 2026 (GLOBE NEWSWIRE) -- GLOBEX MINING ENTERPRISES INC. (GMX – Toronto Stock Exchange, G1MN – Frankfurt, Stuttgart, Berlin, Munich, Tradegate, Lang & Schwarz, LS Exchange,...
April 09, 2026 01:15 ET | Source: Basilea Pharmaceutica International Ltd, Allschwil

Basilea erhält zusätzliche USD 6 Mio. von CARB-X für die klinische Entwicklung des Antibiotikums BAL2420

Zusage der finanziellen Förderung nach erfolgreichem Abschluss präklinischer Studien und Erhalt der Genehmigung zur Durchführung klinischer Studien Zusätzliche USD 6 Mio. für die erstmalige Erprobung...
April 09, 2026 01:15 ET | Source: Basilea Pharmaceutica International Ltd, Allschwil

Basilea awarded additional CARB-X funding of USD 6 million to support the clinical development of antibiotic BAL2420

Funding is awarded following successful completion of IND-enabling studies and clinical study authorization USD 6 million in additional funding to support antibiotic BAL2420 (LptA inhibitor)...
April 08, 2026 09:00 ET | Source: Globex Mining Enterprises Inc.

Feasibility Study on Globex’s Mont Sorcier Royalty Due in Q2

TORONTO, April 08, 2026 (GLOBE NEWSWIRE) -- GLOBEX MINING ENTERPRISES INC. (GMX – Toronto Stock Exchange, G1MN – Frankfurt, Stuttgart, Berlin, Munich, Tradegate, Lang & Schwarz, LS Exchange,...
April 07, 2026 02:40 ET | Source: Renk Group AG

Renk Group AG: Veröffentlichung gemäß § 40 Abs. 1 WpHG mit dem Ziel der europaweiten Verbreitung

Renk Group AG: Veröffentlichung gemäß § 40 Abs. 1 WpHG mit dem Ziel der europaweiten Verbreitung 07. Apr 2026 / 08:39 CET/CEST, übermittelt von GlobeNewswire. Für den Inhalt der...